Moreover, studies have shown that the reduction in CBF mainly accelerates the progression of AD by upregulating the BACE1 enzyme, which produces Aβ, and promoting the overphosphorylation of tau [62, 63, 64]. The gene discussed is MAPT; the disease is Alzheimer disease.